DHVANIT VIJAPURA: Open Payments
NPI 1558338202 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 12 payments from 8 companies in 2025. Trend: 2023 $26,429 · 2024 $1,243 · 2025 $702
Food & beverage: $702
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $271 |
| Vanda Pharmaceuticals Inc. | 2 | $136 |
| Otsuka America Pharmaceutical, Inc. | 1 | $113 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $104 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| ABBVIE INC. | 1 | $19 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: CAPLYTA, REXULTI, FANAPT, COBENFY, VRAYLAR, Quviviq, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
